Search

Author/Creator Avis, Tim

1. 1052. Characterisation of the DNA binding properties of ridinilazole, a selective antibiotic currently in phase III trials for the treatment of Clostridioides difficile. (4th December 2021)

Authors:
Mason, Clive; Avis, Tim; Coward, Chris; Powell, David; Duperchy, Esther; Hu, Chenlin; Jahangir Alam, M; Begum, Khurshida; Garey, Kevin W; Reich, Stefanie; Moss, Stephen
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1052. Characterisation of the DNA binding properties of ridinilazole, a selective antibiotic currently in phase III trials for the treatment of Clostridioides difficile. (4th December 2021)

Authors:
Mason, Clive; Avis, Tim; Coward, Chris; Powell, David; Duperchy, Esther; Hu, Chenlin; Jahangir Alam, M; Begum, Khurshida; Garey, Kevin W; Reich, Stefanie; Moss, Stephen
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. High-density transposon libraries utilising outward-oriented promoters identify mechanisms of action and resistance to antimicrobials. Issue 22 (13th November 2020)

Authors:
Coward, Chris; Dharmalingham, Gopujara; Abdulle, Omar; Avis, Tim; Beisken, Stephan; Breidenstein, Elena; Carli, Natasha; Figueiredo, Luis; Jones, David; Khan, Nawaz; Malara, Sara; Martins, Joana; Nagalingam, Nabeetha; Turner, Keith; Wain, John; Williams, David; Powell, David; Mason, Clive
Journal:
FEMS microbiology letters
Issue:
Volume 367:Issue 22(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗